wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37609420-1F2A0EC6-F687-4C13-BF04-2284E8F80C05
Q37609420-1F2A0EC6-F687-4C13-BF04-2284E8F80C05
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37609420-1F2A0EC6-F687-4C13-BF04-2284E8F80C05
A phase 1 study evaluating the safety and tolerability of otlertuzumab, an anti-CD37 mono-specific ADAPTIR therapeutic protein in chronic lymphocytic leukemia
P2860
Q37609420-1F2A0EC6-F687-4C13-BF04-2284E8F80C05
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37609420-1F2A0EC6-F687-4C13-BF04-2284E8F80C05
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a388eb52b158cc5b6c1fcf3e2e4336e4d159f1be
P2860
Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma.